https://pubmed.ncbi.nlm.nih.gov/38114187
Shenfu Injection improves cardiac function in chronic heart failure by activating the PI3K/Akt/mTOR pathway and inhibiting autophagy.
https://pubmed.ncbi.nlm.nih.gov/38114183
Liujing Toutong Tablets may protect against permanent cerebral ischemia in rats by reducing neuroinflammatory damage and regulating the NF-κB signaling pathway and the CKLF1/CCR5 axis, and exhibiting certain analgesic effects.
https://pubmed.ncbi.nlm.nih.gov/38114181
Zexie Decoction promotes white adipose tissue browning and brown adipose tissue activation, potentially through the GLP-1R/cAMP/PKA/CREB pathway, as demonstrated in a western diet-induced hyperlipidemia mouse model and 3T3-L1 cells.
https://pubmed.ncbi.nlm.nih.gov/38114180
Jiming Powder improves ventricular remodeling and treats myocardial infarction in mice by inhibiting myocardial fibrosis, as demonstrated by reduced myocardial inflammation, collagen deposition, and extracellular matrix metabolism.
https://pubmed.ncbi.nlm.nih.gov/38114179
Xiaoxuming Decoction (XXMD) can improve cerebral ischemia/reperfusion (I/R) injury in rats, potentially by inhibiting astrocyte activation and down-regulating the expression of GFAP and TSP1.
https://pubmed.ncbi.nlm.nih.gov/38114178
Zuogui Jiangtang Jieyu Formula exhibits potential neuroprotective effects in a diabetes mellitus and depression rat model by inhibiting the CX3CL1-CX3CR1 axis and microglia activation, thereby improving neuroinflammation and enhancing the expression of synaptic-related proteins.